Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-25-044407
Filing Date
2025-03-25
Accepted
2025-03-25 16:17:29
Documents
22
Period of Report
2025-03-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A flgt-20250325.htm   iXBRL DEF 14A 1572298
2 GRAPHIC img234008673_0.jpg GRAPHIC 585908
3 GRAPHIC img234008673_1.jpg GRAPHIC 245498
4 GRAPHIC img234008673_2.jpg GRAPHIC 474071
5 GRAPHIC img234008673_3.jpg GRAPHIC 320682
6 GRAPHIC img234008673_4.jpg GRAPHIC 237038
7 GRAPHIC img234008673_5.jpg GRAPHIC 230205
8 GRAPHIC img234008673_6.jpg GRAPHIC 268650
9 GRAPHIC img234008673_7.jpg GRAPHIC 181649
10 GRAPHIC img234008673_8.jpg GRAPHIC 224202
  Complete submission text file 0000950170-25-044407.txt   9720372

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT flgt-20250325.xsd EX-101.SCH 10464
24 EXTRACTED XBRL INSTANCE DOCUMENT flgt-20250325_htm.xml XML 560828
Mailing Address 4399 SANTA ANITA AVE EL MONTE CA 91731
Business Address 4399 SANTA ANITA AVE EL MONTE CA 91731 626-350-0537
Fulgent Genetics, Inc. (Filer) CIK: 0001674930 (see all company filings)

EIN.: 812621304 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37894 | Film No.: 25768529
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)